Publicaciones en colaboración con investigadores/as de Universidad de Cantabria (19)

2021

  1. Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLLrearranged B cell acute lymphoblastic leukemia

    Journal of Clinical Investigation, Vol. 131, Núm. 13

2020

  1. A spotlight on cancer researchers in Spain: new paradigms and disruptive ideas

    Clinical and Translational Oncology

  2. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells

    Journal of Biological Chemistry, Vol. 295, Núm. 7, pp. 2001-2017

2019

  1. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27

    Scientific Reports, Vol. 9, Núm. 1

2016

  1. CD3ε recruits Numb to promote TCR degradation

    International Immunology, Vol. 28, Núm. 3, pp. 127-137

2015

  1. Myc and cell cycle control

    Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1849, Núm. 5, pp. 506-516

  2. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer

    Oncotarget, Vol. 6, Núm. 8, pp. 5903-5917

  3. Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design

    Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 308-315

2014

  1. High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle

    Oncotarget, Vol. 5, Núm. 13, pp. 4694-4708

2013

  1. MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27 KIP1

    Oncogene, Vol. 32, Núm. 17, pp. 2239-2246

2012

  1. MYC accelerates p21 CIP-induced megakaryocytic differentiation involving early mitosis arrest in leukemia cells

    Journal of Cellular Physiology, Vol. 227, Núm. 5, pp. 2069-2078

  2. P21 as a transcriptional co-repressor of S-phase and mitotic control genes

    PLoS ONE, Vol. 7, Núm. 5

  3. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia

    Swiss Medical Weekly, Vol. 142, Núm. MARCH

2011

  1. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27 KIP1 through SKP2 in human leukemia cells

    Journal of Biological Chemistry, Vol. 286, Núm. 11, pp. 9815-9825

2008

  1. Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest

    Molecular and Cellular Biology, Vol. 28, Núm. 24, pp. 7286-7295

  2. c-Myc inhibits ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation

    Molecular Cancer Research, Vol. 6, Núm. 2, pp. 325-339

2007

  1. Phosphorylation of human eukaryotic elongation factor 1Bγ is regulated by paclitaxel

    Proteomics, Vol. 7, Núm. 18, pp. 3299-3304

2006

  1. Effect of Vinca alkaloids on ERα levels and estradiol-induced responses in MCF-7 cells

    Breast Cancer Research and Treatment, Vol. 98, Núm. 1, pp. 81-89

1999

  1. Identification and chromosomal location of two human genes encoding enzymes potentially involved in proteolytic maturation of farnesylated proteins

    Genomics, Vol. 58, Núm. 3, pp. 270-280